Related Experiment Videos
Mutations of the RET-GDNF signaling pathway in Ondine's curse
American Journal of Human Genetics
|April 29, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Spectrum of NSD1 mutations in Sotos and Weaver syndromes.
Journal of medical genetics·2003
[Preimplantation genetic diagnosis and its psychological effects].
Journal de gynecologie, obstetrique et biologie de la reproduction·2003
Homozygosity mapping of a Desbuquois dysplasia locus to chromosome 17q25.3.
Journal of medical genetics·2003
Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells.
Lancet (London, England)·2003
Identification of seven novel mutations in the GAN gene.
Human mutation·2003
A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity.
American journal of human genetics·2026
CanVar-UK: A collaborative platform for germline interpretation in cancer susceptibility genes.
American journal of human genetics·2026
Distinct cochlear cell types associated with genetic susceptibility to sensory and metabolic hearing loss in older adults.
American journal of human genetics·2026
Functional characterization of the 9q34.13 locus identifies RAPGEF1 as a candidate gene modulating risk for melanoma and nevi via RAS activation.
American journal of human genetics·2026
Monoallelic loss-of-function variants in ZNF536 are associated with a neurodevelopmental disorder with prominent behavioral features.
American journal of human genetics·2026
Beyond exons: Linking noncoding heritability and polygenicity across complex human traits and disorders.
American journal of human genetics·2026
Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.
Asian journal of andrology·2026
Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.
Expert opinion on investigational drugs·2026